Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, May 19, 2022
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
[ Thu, May 19th 2022
] - WOPRAI
Joshua Dennerlein Downgraded (DOC) to Sell and Held Target at $18 on, May 19th, 2022
Joshua Dennerlein of B of A Securities, Downgraded "Healthpeak Properties, Inc." (DOC) to Sell and Held Target at $18 on, May 19th, 2022.
Joshua has made no other calls on DOC in the last 4 months.
There are 4 other peers that have a rating on DOC. Out of the 4 peers that are also analyzing DOC, 3 agree with Joshua's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Michael Carroll of "RBC Capital" Maintained at Hold with Decreased Target to $18 on, Wednesday, March 9th, 2022
- Richard Hill of "Morgan Stanley" Maintained at Hold with Decreased Target to $18 on, Monday, March 7th, 2022
- Tayo Okusanya of "Credit Suisse" Initiated at Hold and Held Target at $19 on, Tuesday, February 1st, 2022
This is the rating of the analyst that currently disagrees with Joshua
- Steve Valiquette of "Barclays" Initiated at Buy and Held Target at $20 on, Tuesday, April 26th, 2022
